文献速递肿瘤 PET/CT

18F-Fluciclovine PET/CT意外发现AB型胸腺瘤摄取

Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma.
PubMed 文献 · Clin Nucl Med · 2022-01-01

本文报告一例71岁男性前列腺癌生化复发患者,18F-Fluciclovine PET/CT未见明确前列腺癌复发灶,但前纵隔出现意外摄取,活检证实为AB型胸腺瘤。作者强调认识假阳性摄取模式对准确诊断复发性前列腺癌至关重要。

要点

  • 18F-Fluciclovine PET/CT可用于定位复发性前列腺癌。
  • 本例前纵隔意外摄取经活检证实为AB型胸腺瘤。
  • 认识假阳性摄取模式对准确诊断复发性前列腺癌至关重要。

核心结论

  • 认识18F-Fluciclovine PET/CT的假阳性摄取模式对准确诊断复发性前列腺癌至关重要。

研究设计与样本

  • 本文为病例报告,报告一例71岁男性前列腺癌生化复发患者。

主要发现

  • 患者因前列腺癌生化复发(PSA升高)行18F-Fluciclovine PET/CT,未见明确前列腺癌复发影像学表现。
  • 18F-Fluciclovine PET/CT显示前纵隔意外摄取,活检证实为AB型胸腺瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biochemical recurrence of prostate cancer, detected by a rising PSA, may reflect intraprostatic or extraprostatic recurrence. 18F-Fluciclovine (Axumin), a synthetic amino acid substrate in tumor metabolism, has frequently been used for to localize recurrent prostate cancers. We present a 71-year-old man with biochemical recurrence of prostate cancer but no convincing imaging findings on 18F-fluciclovine PET/CT. Of note, however, was an incidental uptake within the anterior mediastinum, which was found on biopsy to be a type AB thymoma. With this, we stress that awareness of false-positive uptake patterns is crucial for accurate diagnosis of recurrent prostate cancer.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Somnay V, Dalal I. Incidental Uptake of 18F-Fluciclovine by Type AB Thymoma. Clin Nucl Med. 2022. PMID: 35006112. doi:10.1097/RLU.0000000000004024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。